BusinessIn Wales

Transport for Wales
Transport & Infrastructure, Uncategorised

Transport for Wales to improve crowd management ahead of six nations finale

Transport for Wales to improve crowd management ahead of six nations finale Transport for Wales to improve crowd management ahead of six nations finale max taylor – journalist Subscribe to the Businessin Wales daily newsletter for FREE here.  Transport for Wales (TfW) will trial a new post match crowd management approach for the upcoming Six Nations fixture aimed at improving the match day experience for fans and prepare for major works at Cardiff Central. Cardiff Queen Street will be the destination for fans using the Valley’s and Vale lines next weekend instead of the rear of Cardiff Central Station. This is due to this area being redeveloped as part of Transport for Wales’ enhancements project, which will make it unavailable on the matchday. This directs fans further away from the Principality stadium but will result in a more seamless transition in and out of the station, with shorter waits and faster boarding. This development sees stations in the Vale such as Cardiff Bay, Barry Island, Penarth, Bridgend and Valleys stations such as Bargoed, Caerphilly, Rhymney, Coryton, Ystrad Mynach, and more all sent to Queen Street. To ensure a faster transition through the station, fans are encouraged to use the contactless ‘tap on-tap off’ system through the barriers. Georgina Porter, Customer Delivery and Events Planning Manager for Transport for Wales said: “We’re preparing for the £140 million redevelopment of Cardiff Central station and looking at the best ways to get people home on event days “This event gives us the perfect opportunity to work with our customers to test a smarter, more targeted approach to moving large numbers of fans out of the city. “Keeping Cardiff Queen Street open for Valleys and Vale services allows us to ease pressure on Cardiff Central station, distribute passenger flow more effectively and get people home sooner. “These changes give us the opportunity to engage with our customers more effectively on the day, with teams on the ground making sure everyone gets to the right place. We’ll continue to adapt our plans based on what we learn from the trial.” Want more from Businessin Wales? Why not follow us on our socials Linkedin X Instagram TikTok Listen to the Businessin Wales podcast YouTube Spotify Apple Podcasts

Uncategorised

Reacta Healthcare appoints Richard Nagle as chair to support growth strategy

Reacta Healthcare appoints Richard Nagle as chair to support growth strategy Reacta Healthcare appoints Richard Nagle as chair to support growth strategy Daniel Bevan – Editor Subscribe to the Businessin Wales daily newsletter for FREE here.  Deeside-based diagnostics company Reacta Healthcare has appointed life sciences entrepreneur Richard Nagle as Chair of its Board of Directors. The company, which develops food allergy diagnostic products, said Nagle’s arrival comes at a key stage in its growth as it seeks to scale internationally and advance its innovation pipeline. Nagle brings more than 30 years’ experience across the pharmaceutical, biotechnology and medical technology sectors, including expertise in immunology.  Over his career, he has founded and led multiple companies, secured tens of millions of dollars in investment and overseen operational transformations during periods of rapid growth. Among his previous leadership roles, he served as Strategic Advisor and CEO at Immune Regulation, now Revolo Biotherapeutics and formerly Peptinnovate, where he led strategic development, clinical programmes and corporate growth initiatives.  Professor Ashley Woodcock, a co-founder of Reacta Healthcare who has served as chair since the company’s inception, will remain with the business as a non-executive director. Dr Paul Abrahams, Reacta Healthcare CEO, said: “We are thrilled to have Richard join us at such a pivotal time in the Company’s growth trajectory.  “His specific knowledge in the immunology space and broad experience in finance, corporate strategy and product development adds huge value and strengthens our strategic leadership.  “The senior team and I are looking forward to working with Richard to refine and deliver on an ambitious strategy for 2026 and beyond. “We are hugely grateful to Ashley for his entrepreneurial leadership, guidance and support of Reacta to date and look forward to his ongoing contribution to the business as a Non-Executive Director.” Richard Nagle, Reacta Healthcare Chair added: “This is an extremely exciting time for Reacta, and I am delighted to be joining this dynamic business.  “Reacta has been at the forefront of food allergy diagnostics R&D and counts many of the leading companies in the allergy therapeutic development space as its partners.  “Our aim now is to continue to expand our presence both in the UK and internationally, delivering solutions that improve the safety, accuracy and efficiency of food allergy testing. “Reacta has built a world class team to execute on its future development goals, and I look forward to working with Paul and the management team in helping them to realise maximum value from its pioneering products and deep innovation pipeline.” The appointment follows a period of rapid growth for the company, which was recently ranked 12th in the The Sunday Times Tech100 list of fastest-growing private technology companies for 2026, after expanding its multi-allergen product range to include milk and egg alongside its established peanut challenge meals. Want more from Businessin Wales? Why not follow us on our socials Linkedin X Instagram TikTok Listen to the Businessin Wales podcast YouTube Spotify Apple Podcasts

Scroll to Top